ArticleFrontiers in pediatrics2026
Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Posterior reversible encephalopathy syndrome (PRES) is an uncommon but critical neurological emergency in children. Data on Chinese pediatric cohorts remain limited. Objective: To analyze the clinical features, imaging findings, and treatment of PRES in children to improve early diagnosis and management. Methods: A retrospective analysis was conducted on 10 children diagnosed with PRES from March 2016 to January 2025. Results: The patients included 7 males and 3 females, aged 3-13 years (mean 7.5 years). The main underlying diseases were acute lymphoblastic leukemia (3 cases) and nephrotic syndrome (3 cases). Eight children (80%) had hypertension, 6 (60%) had hypoalbuminemia, and 8 received glucocorticoids or immunosuppressants. The main symptoms were headache, seizures, impaired consciousness, and visual disturbances. Cranial MRI showed symmetrical long T1 and long T2 signals in bilateral posterior cerebral white matter. After comprehensive treatment including antihypertensive, anticonvulsant, and dehydration therapy, all symptoms resolved and lesions disappeared on follow-up imaging without sequelae. Conclusion: Pediatric PRES is an acute reversible disorder associated with hypertension and immunosuppressive therapy. Early MRI diagnosis and prompt intervention can significantly improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.